Institutional investors purchased a net $152.3 thousand shares of ABIO during the quarter ended June 2016 and now own 48.21% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
AVEO CAPITAL PARTNERS LLC Bought 231.8 Thousand shares of ARCA Biopharma Inc